Literature DB >> 8417705

Emergency resuscitation using portable extracorporeal membrane oxygenation.

W P Dembitsky1, R J Moreno-Cabral, R M Adamson, P O Daily.   

Abstract

Manual cardiopulmonary resuscitation is currently the standard treatment for cardiac arrest patients both in and out of the hospital. Accumulated experimental and anecdotal clinical evidence suggests enhanced survival in patients with extreme circulatory decompensation who have been emergently supported with portable cardiopulmonary bypass. Long-term survival is possible even when application is delayed, but early institution of support after cardiac arrest in selected patients offers the best survival advantages. In our hospital this has been achieved by training a team of in-house personnel to emergently prepare, apply, and temporarily manage cardiopulmonary bypass until personnel with greater specialty training arrive. Machinery needed to perform emergency cardiopulmonary bypass is currently available in all hospitals with open heart surgery programs. Simple support is often therapeutic but can also serve as a bridge to definitive diagnostic and other therapeutic procedures. Commercial units are becoming more biocompatible and easier to use, making both wider application and more prolonged support likely in the future.

Entities:  

Mesh:

Year:  1993        PMID: 8417705     DOI: 10.1016/0003-4975(93)90542-p

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Mechanical cardiopulmonary support in children and young adults: extracorporeal membrane oxygenation, ventricular assist devices, and long-term support devices.

Authors:  A C Chang; E D McKenzie
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

2.  [Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients].

Authors:  Gerald Vanzetto; Chrystelle Akret; Vincent Bach; Gilles Barone; Michel Durand; Olivier Chavanon; Rachid Hacini; Hélène Bouvaist; Jacques Machecourt; Dominique Blin
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

3.  Emergency cardiopulmonary bypass support in patients with severe cardiogenic shock after acute myocardial infarction.

Authors:  R Matsuwaka; T Sakakibara; H Shintani; A Yagura; T Masai; A Hirayama; K Kodama
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

4.  Extracorporeal life support following out-of-hospital refractory cardiac arrest.

Authors:  Morgan Le Guen; Armelle Nicolas-Robin; Serge Carreira; Mathieu Raux; Pascal Leprince; Bruno Riou; Olivier Langeron
Journal:  Crit Care       Date:  2011-01-18       Impact factor: 9.097

5.  Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure.

Authors:  Alexander Weymann; Bastian Schmack; Anton Sabashnikov; Christopher T Bowles; Philipp Raake; Rawa Arif; Markus Verch; Ursula Tochtermann; Jens Roggenbach; Aron Frederik Popov; Andre Ruediger Simon; Matthias Karck; Arjang Ruhparwar
Journal:  J Cardiothorac Surg       Date:  2014-03-29       Impact factor: 1.637

Review 6.  Capnography during cardiopulmonary resuscitation: Current evidence and future directions.

Authors:  Bhavani Shankar Kodali; Richard D Urman
Journal:  J Emerg Trauma Shock       Date:  2014-10

7.  The top 100 manuscripts in emergency cardiac surgery. Potential role in cardiothoracic training. A bibliometric analysis.

Authors:  Rickesh B Karsan; Arfon Gmt Powell; Prakash Nanjaiah; Dheeraj Mehta; Vasileious Valtzoglou
Journal:  Ann Med Surg (Lond)       Date:  2019-05-14

8.  Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in pheochromocytoma.

Authors:  Il-Woo Suh; Cheol Whan Lee; Young-Hak Kim; Myeong-Ki Hong; Jae-Won Lee; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.